Social networks
3,126 5,674Activities
Entity types
Location
213 Rue de Gerland Bâtiment C, 69007 Lyon, France
Lyon
France
Employees
Scale: 2-10
Estimated: 14
SIREN
337607303Engaged corporates
49Added in Motherbase
5 years, 7 months agoThe goal of the Cancéropôle (cancer cluster) Lyon Auvergne Rhône-Alpes (CLARA) is to structure and facilitate cancer research in the French Rhône-Alpes Auvergne inter region by bringing together academic, clinical and industrial strengths in order to develop a network with a European dimension.
CLARA is distinct from the six other French cancéropôles due to its amplitude of funding by local authorities.
This particular feature confers strong economic objectives, on top of the objectives related to scientific excellence and public health as presented in the French Cancer Plans.
An important feature of CLARA’s strategy is to promote cancer research applications with clear industrial objectives.
The CLARA Cancer Research Cluster strives to bringing together researchers, clinicians and industrial partners into a single network, and to pool their efforts on operational research programs with a two-fold objective of quickly transferring knowledge to patient care and developing marketable applications of research findings.
From the laboratory to industrial production, CLARA constitutes a missing link by promoting the industrial transfer and commercial development of an idea.
Leading a program to support innovative, high-potential projects in the area of health/oncology/biotechnology, called “Proof of Concept”, the Cancéropôle is making a difference, confirming its role as a dynamic actor of economic development.
Cancer Cluster, Cancer Research Network, Proof of Concept, Academic/clinical and Industrial Partnerships, Oncology Scientific Events, Regulatory Issues related to Clinical Transfer, recherche clinique, vulgarisation scientifique, événement scientifique, financement de projets de recherche, and international
Sur la base d'une initiative régionale impulsée en 2001, le
Cancéropôle Lyon Auvergne-Rhône-Alpes est soutenu par les
pouvoirs publics depuis 2003 dans le cadre des Plans Cancer
nationaux. Il a pour objectif de développer et valoriser la recherche
en cancérologie en Auvergne-Rhône-Alpes.
Le CLARA est un animateur de réseau. Il fédère les acteurs
académiques, nationaux et internationaux de lutte contre le cancer
dans un double objectif : le transfert rapide des découvertes vers les
patients et la valorisation économique de la recherche.
www.canceropole-clara.com
Le Cancéropôle est soutenu par la Fondation Innovation et Transitions.
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Pfizer Pharmaceutical, Pharmaceutical Manufacturing | Other 18 Mar 2021 3 May 2023 | | |
Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Greater Paris University Hospitals - AP-HP Health, Hospitals and Health Care | Other 8 Sep 2024 | | |
Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Johnson & Johnson Pharmaceutical, Hospitals and Health Care | Other 19 Apr 2021 3 May 2023 | | |
Pouss@LYS Financial Services | Pouss@LYS Financial Services | Other 31 Aug 2024 | | |
Clermont Auvergne Innovation Research, Research Services | Clermont Auvergne Innovation Research, Research Services | Other 8 Apr 2021 27 Jun 2023 | | |
PULSALYS Research, Research Services | PULSALYS Research, Research Services | Other 29 Sep 2021 17 Jul 2024 | | |
Eurostat European Union, Environmental Services | Eurostat European Union, Environmental Services | Other 20 Mar 2023 | | |
AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | AstraZeneca Pharmaceutical, Pharmaceutical Manufacturing | Other 21 Jan 2022 | | |
CNRS Research, Research Services | CNRS Research, Research Services | Other 30 Jan 2024 | |